Recipient age at baseline and the CYP3A phenotype were also found to be variability factors over D8-M3 and M3-12, whereas the use of corticosteroids, diabetes at baseline, and ASAT yielded inconstant results between D8-M3 and M3-M12. This evidence concerns the gene CYP3A4 and diabetes mellitus.